# CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Organization · id `cardio:org-cspc-zhongnuo-pharmaceutical-shijiazhuang-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=CSPC+Zhongnuo+Pharmaceutical+%28Shijiazhuang%29+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency (`cardio:ct-nct05783557`)
- Sponsors: A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia (`cardio:ct-nct07421232`)
- Sponsors: A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy (`cardio:ct-nct07421284`)
- Sponsors: A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia (`cardio:ct-nct07421297`)
- Sponsors: A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia (`cardio:ct-nct07695597`)

## Provenance

Content hash: 0ca5bda42b75924c87358b9fcf7f5ad716be38fe9bd2dc1177c00f4644e25180
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
